Abstract | BACKGROUND/AIM: MATERIALS AND METHODS: RESULTS: Histopathologically prevalent inflammation and cartilage/bone destruction were observed in the arthritis group. Moreover, in the arthritis group serum IL-17, TNF-α, and malondialdehyde levels were significantly increased while catalase, SOD, GPx, HO-1, and Nrf2 levels were significantly decreased. However, in the GEM-treated groups, decreased TNF-α, IL-17, and malondialdehyde levels; increased SOD, catalase, GPx, Nrf2, and HO-1 levels; and ameliorated perisynovial inflammation and cartilage/bone destruction were observed. CONCLUSION: GEM suppresses cytokine levels and enhances antioxidant activity. It also prevents cartilage/bone destruction in the CIA model. GEM may be a viable candidate for research into the treatment of RA.
|
Authors | Adile Ferda Dağli, Ahmet Karataş, Cemal Orhan, Mehmet Tuzcu, Metin Özgen, Kazım Şahin, Süleyman Serdar Koca |
Journal | Turkish journal of medical sciences
(Turk J Med Sci)
Vol. 47
Issue 3
Pg. 1037-1044
(Jun 12 2017)
ISSN: 1300-0144 [Print] Turkey |
PMID | 28618762
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Antioxidants
- Cytokines
- Deoxycytidine
- Collagen
- Oxidoreductases
- Gemcitabine
|
Topics |
- Animals
- Anti-Inflammatory Agents
(pharmacology)
- Antioxidants
(pharmacology)
- Arthritis, Experimental
(chemically induced, metabolism)
- Arthritis, Rheumatoid
(chemically induced, metabolism)
- Bone and Bones
(drug effects, pathology)
- Collagen
(adverse effects)
- Cytokines
(blood)
- Deoxycytidine
(analogs & derivatives, pharmacology)
- Inflammation
- Oxidoreductases
(metabolism)
- Rats
- Rats, Wistar
- Gemcitabine
|